骨髓增生异常综合征中1;7易位背后的独特表观遗传程序
该研究对伴有dic(1;7)(q10;p10)的骨髓增生异常综合征(MDS)进行了首次综合遗传与表观遗传分析,与正常对照及治疗相关髓系肿瘤(t-MNs)比较。RNA-seq显示dic(1;7)病例存在独特的下调表达特征,影响超过80%的差异表达基因。表观遗传分析发现该亚组增强子高甲基化,且1q异常基因中超过50%的低表达由特定高甲基化模式所致。
要点
- dic(1;7)病例RNA-seq显示独特下调特征,影响超过80%差异表达基因。
- 该亚组增强子区高甲基化,低表达增强子靶基因约占下调特征的35%。
- 1q三体背景下,超过50%的1q异常基因低表达由特定高甲基化模式所致。
核心结论
- MDS中的dic(1;7)建立了一个由独特表观基因组特征驱动的特定转录程序。
研究设计与样本
- 对伴有dic(1;7)(q10;p10)的MDS进行首次综合遗传与表观遗传分析,与正常对照及治疗相关髓系肿瘤(t-MNs)比较。
主要发现
- RNA-seq显示dic(1;7)病例存在独特下调特征,影响超过80%的差异表达基因。
- 通路与基因本体分析显示,ABC转运蛋白及脂质相关基因下调、p53信号上调是dic(1;7)最相关的生物学特征。
- 表观遗传监督分析显示dicentric亚组内含子增强子高甲基化,低表达增强子靶基因约占下调特征的35%。
- 增强子处富集Krüppel样转录因子结合位点。
- 1q存在特定高甲基化模式,导致超过50%的1q异常基因低表达,尽管存在三体。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The unbalanced translocation dic(1;7)(q10;p10) in myelodysplastic syndromes (MDS) is originated by centromeric juxtaposition resulting into 1q trisomy and 7q monosomy. More than half of cases arise after chemo/radio-therapy. To date, given the absence of genes within the centromeric regions, no specific molecular events have been identified in this cytogenetic subgroup. We performed the first comprehensive genetic and epigenetic analysis of MDS with dic(1;7)(q10;p10) compared to normal controls and therapy-related myeloid neoplasms (t-MNs). RNA-seq showed a unique downregulated signature in dic(1;7) cases, affecting more than 80% of differentially expressed genes. As revealed by pathway and gene ontology analyses, downregulation of ATP-binding cassette (ABC) transporters and lipid-related genes and upregulation of p53 signaling were the most relevant biological features of dic(1;7). Epigenetic supervised analysis revealed hypermethylation at intronic enhancers in the dicentric subgroup, in which low expression levels of enhancer putative target genes accounted for around 35% of the downregulated signature. Enrichment of Krüppel-like transcription factor binding sites emerged at enhancers. Furthermore, a specific hypermethylated pattern on 1q was found to underlie the hypo-expression of more than 50% of 1q-deregulated genes, despite trisomy. In summary, dic(1;7) in MDS establishes a specific transcriptional program driven by a unique epigenomic signature.
引用
- Fernandez AGL, Crescenzi B, Pierini V, et al. A distinct epigenetic program underlies the 1;7 translocation in myelodysplastic syndromes. Leukemia. 2019. PMID: 30923319. doi:10.1038/s41375-019-0433-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。